By Joe Hoppe
Ergomed PLC said Wednesday that it expects to report an adjusted Ebitda for 2022 in line with market expectations while revenue rose, and appointed Jonathan Curtain as incoming chief financial officer.
The services provider to the pharma industry said revenue for the year ended Dec. 31 rose 23% to 145.3 million pounds ($179.1…
Read the full article here
Discussion about this post